Speaking at the J.P. Morgan health conference CEO Jason Gorevic said Monday he expects sustainable long-term growth for the company, with 30% to 40% average annual revenue growth expected through 2023.
Show CommentsClose Comments
Speaking at the J.P. Morgan health conference CEO Jason Gorevic said Monday he expects sustainable long-term growth for the company, with 30% to 40% average annual revenue growth expected through 2023.